(Hypertension. 2001;37:677.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology, College of Medicine, and the University of Florida McKnight Brain Institute, Gainesville, Fla.
Correspondence to Mohan K. Raizada, PhD, Department of Physiology, University of Florida College of Medicine, PO Box 100274, Gainesville, FL 32610. E-mail mraizada{at}phys.med.ufl.edu
Our
previous studies have established that angiotensin (Ang) II
stimulates the release, uptake, and synthesis of
norepinephrine (NE) in brain neurons involving distinct
signal transduction pathways. However, little is known if this NE
neuromodulatory effect is a result of Ang II activation of vesicular
trafficking in the catecholaminergic neurons. Thus, the aim
of this study was to determine if Ang II influences movement of
vesicles in live neurons. Dopamineß-hydroxylase (DßH) fused to
green fluorescence protein (GFP) has been used to trace
vesicular movement in live neurons by confocal microscopy. Transfection
by a plasmid containing GFP-DßH resulted in the expression of green
fluorescence, representing
100 kDa GFP-DßH
fusion protein. The fluorescence was predominantly localized in
the perinuclear region of the neuronal soma, with a few neurites also
depicting the fluorescence. Ang II caused a dramatic
redistribution of fluorescence. The fluorescence was
translocated to the neurites in a time-dependent manner. As a result,
the number of neurites depicting fluorescence was significantly
increased. The translocation was blocked by losartan, an Ang II
type 1 receptor subtypespecific antagonist and not by
PD123319, an Ang II type 2 receptor subtype antagonist.
High-magnification confocal microscopic examination revealed that Ang
II treatment resulted in a distal movement of certain
fluorescent clusters in the neurites at an average rate of
0.84±0.2 µm/s. These observations suggest increased vesicular
trafficking is a key signaling event in Ang II stimulation of NE
neuromodulation.
Key Words: dopamine norepinephrine neuroregulators hypothalamus brain receptors, angiotensin
This article has been cited by other articles:
![]() |
K. Klein, M. Daschner, M. Vogel, J. Oh, T. J. Feuerstein, and F. Schaefer Impaired Autofeedback Regulation of Hypothalamic Norepinephrine Release in Experimental Uremia J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2081 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. F. de Godoy and A. M. de Oliveira Cross-Talk Between AT1 and AT2 Angiotensin Receptors in Rat Anococcygeus Smooth Muscle J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 333 - 339. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |